Search

Nu Skin Enterprises Inc

Gesloten

10.31 2.49

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

9.89

Max

10.32

Belangrijke statistieken

By Trading Economics

Inkomsten

-4M

17M

Verkoop

-22M

364M

K/W

Sectorgemiddelde

4.466

15.467

EPS

0.34

Dividendrendement

2.5

Winstmarge

4.689

Werknemers

3,100

EBITDA

-11M

32M

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

2.50%

7.13%

Volgende Winsten

12 feb 2026

Volgende dividenddatum

4 mrt 2026

Volgende Ex Dividend datum

23 feb 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-53M

477M

Vorige openingsprijs

7.82

Vorige sluitingsprijs

10.31

Technische score

By Trading Central

Vertrouwen

Bearish Evidence

Nu Skin Enterprises Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

7 jan 2026, 23:11 UTC

Winsten

Samsung Electronics Expects Record Fourth-Quarter Profit Beat

7 jan 2026, 22:55 UTC

Belangrijke Marktbewegers

Defense Stocks Rebound After Trump Says He Wants $1.5 Trillion Military Budget in 2027

7 jan 2026, 21:39 UTC

Belangrijke Marktbewegers

Raytheon Down Following Trump Post Criticizing Company

7 jan 2026, 20:13 UTC

Belangrijke Marktbewegers

AbbVie, Revolution Medicines Stocks Gain on Report of Possible Acquisition

7 jan 2026, 20:03 UTC

Belangrijke Marktbewegers

Defense Contractor Shares Fall on Trump's Push to Ban Industry Dividends, Buybacks, Limit Executive Pay

7 jan 2026, 23:46 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

7 jan 2026, 23:46 UTC

Marktinformatie

Nikkei May Decline as China-Japan Tensions Linger -- Market Talk

7 jan 2026, 23:42 UTC

Acquisities, Fusies, Overnames

Warner Discovery Rejects Paramount's Amended Hostile Bid -- 5th Update

7 jan 2026, 23:34 UTC

Marktinformatie

Gold Edges Higher Amid Lingering Geopolitical Risks -- Market Talk

7 jan 2026, 23:29 UTC

Acquisities, Fusies, Overnames

Constellation Closes Deal for Calpine, Creating Biggest Electricity Generator -- Barrons.com

7 jan 2026, 22:48 UTC

Marktinformatie

Infratil's Discount to Net Asset Value Too Good to Ignore -- Market Talk

7 jan 2026, 22:46 UTC

Winsten

Samsung Electronics Estimates 2025 Rev KRW332.770T Vs KRW300.870T >005930.SE

7 jan 2026, 22:45 UTC

Winsten

Samsung Electronics Estimates 2025 Oper Pft KRW43.530T Vs KRW32.730T >005930.SE

7 jan 2026, 22:43 UTC

Acquisities, Fusies, Overnames

Revolution Medicines Draws Takeover Interest -- 2nd Update

7 jan 2026, 22:42 UTC

Winsten

Samsung Electronics 4Q Oper Pft Estimate Beat FactSet-Compiled Consensus Forecast

7 jan 2026, 22:41 UTC

Winsten

Samsung Electronics Sees 4Q Oper Pft KRW20.000T Vs KRW6.490T >005930.SE

7 jan 2026, 22:41 UTC

Winsten

Samsung Electronics Sees 4Q Rev KRW93.000T Vs KRW75.790T >005930.SE

7 jan 2026, 22:40 UTC

Belangrijke Marktbewegers

Defense Stocks Rebound After Trump Says He Wants $1.5T Military Budget in 2027

7 jan 2026, 22:31 UTC

Marktinformatie

Macro Tailwinds Strengthen for Chalice Mining -- Market Talk

7 jan 2026, 22:22 UTC

Marktinformatie

Northern Star's Run of Disruptions Increasingly a Concern -- Market Talk

7 jan 2026, 22:01 UTC

Marktinformatie

Valuations of New Zealand Property Stocks Supportive -- Market Talk

7 jan 2026, 21:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

7 jan 2026, 21:46 UTC

Marktinformatie

Northern Star's Revised Guidance Looks Achievable -- Market Talk

7 jan 2026, 21:22 UTC

Acquisities, Fusies, Overnames

Eli Lilly to Buy Ventyx Biosciences for $14 a Share >LLY VTYX

7 jan 2026, 21:18 UTC

Acquisities, Fusies, Overnames

Lilly To Acquire Ventyx Biosciences To Advance Oral Therapies Targeting Inflammatory-mediated Diseases >LLY VTYX

7 jan 2026, 21:05 UTC

Acquisities, Fusies, Overnames

Warner Discovery Rejects Paramount's Amended Hostile Bid -- 4th Update

7 jan 2026, 20:29 UTC

Acquisities, Fusies, Overnames

AbbVie Near Deal for Revolution Medicines -- Update

7 jan 2026, 20:27 UTC

Marktinformatie

U.S. Natural Gas Futures Snap Losing Streak -- Market Talk

7 jan 2026, 19:58 UTC

Marktinformatie

Oil Falls As U.S. to Receive Sanctioned Venezuelan Crude -- Market Talk

7 jan 2026, 19:48 UTC

Belangrijke Marktbewegers

Defense Contractor Shares Fall on Trump's Push to Ban Industry Dividends, Buybacks, Limit Exec Pay

Nu Skin Enterprises Inc Prognose

Beoordelingsconsensus

By TipRanks

0 ratings

0

Buy

0

Hold

0

Sell

Technische score

By Trading Central

5.78 / 6.16Steun & Weerstand

Korte Termijn

Bearish Evidence

Gemiddeld Termijn

Strong Bearish Evidence

Lange Termijn

Neutral Evidence

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Nu Skin Enterprises Inc

Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products. The company also provides wellness products, such as LifePak nutritional supplements, ageLOC TR90 weight management system, and Beauty Focus Collagen+. In addition, it is involved in the research and product development of skin care products and nutritional supplements. The company sells its products under the Nu Skin, Pharmanex, and ageLOC brands through retail stores, website, digital platforms, and independent direct sellers and marketers, as well as a service center. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.
help-icon Live chat